Exact Mass: 1348.7155628

Exact Mass Matches: 1348.7155628

Found 9 metabolites which its exact mass value is equals to given mass value 1348.7155628, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   
   
   

ikemagenin 3-O-beta-D-glucopyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-digitoxopyranosyl-(1->4)-beta-D-canaropyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-cymaropyranoside

ikemagenin 3-O-beta-D-glucopyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-digitoxopyranosyl-(1->4)-beta-D-canaropyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-cymaropyranoside

C69H104O26 (1348.6815483999999)


   

(2beta,3beta,4alpha,16alpha)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-2,16,23-trihydroxy-olean-12-en-28-oic acid O-6-deoxy-alpha-L-mannopyranosyl-(1->3)-O-beta-D-xylopyranosyl-(1->4)-O-2-O-acetyl-6-deoxy-alpha-L-mannopyranosyl-(1->2)-6-deoxy-4-O-[(3S)-3-hydroxy-1-oxobutyl]-beta-D-galactopyranosyl ester|3-O-alpha-L-rhamnopyranosylpolygalacic acid 28-[O-alpha-L-rhamnopyranosyl-(1->3)-O-beta-D-xylopyranosyl-(1->4)-O-2-O-acetyl-alpha-L-rhamnopyranosyl-(1->2)-4-O-(3S)-3-hydroxybutanoyl-beta-D-fucopyranosyl] ester|perennisaponin I

(2beta,3beta,4alpha,16alpha)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-2,16,23-trihydroxy-olean-12-en-28-oic acid O-6-deoxy-alpha-L-mannopyranosyl-(1->3)-O-beta-D-xylopyranosyl-(1->4)-O-2-O-acetyl-6-deoxy-alpha-L-mannopyranosyl-(1->2)-6-deoxy-4-O-[(3S)-3-hydroxy-1-oxobutyl]-beta-D-galactopyranosyl ester|3-O-alpha-L-rhamnopyranosylpolygalacic acid 28-[O-alpha-L-rhamnopyranosyl-(1->3)-O-beta-D-xylopyranosyl-(1->4)-O-2-O-acetyl-alpha-L-rhamnopyranosyl-(1->2)-4-O-(3S)-3-hydroxybutanoyl-beta-D-fucopyranosyl] ester|perennisaponin I

C65H104O29 (1348.6662934)


   

PIM3 36:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C63H113O28P (1348.7155628)


   

Lopinavir and ritonavir

Lopinavir and ritonavir

C74H96N10O10S2 (1348.6751955999998)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AR - Antivirals for treatment of hiv infections, combinations COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   

3-{[3-(acetyloxy)-5-({3,5-dihydroxy-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-5-[(3-hydroxybutanoyl)oxy]-6-methyloxan-2-yl 5,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

3-{[3-(acetyloxy)-5-({3,5-dihydroxy-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-5-[(3-hydroxybutanoyl)oxy]-6-methyloxan-2-yl 5,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C65H104O29 (1348.6662934)